Later that same month, Novo Nordisk, the pharmaceutical company that makes Ozempic, Wegovy and Rybelsus, announced it was taking legal action against certain medical spas, weight loss or wellness clinics, and compounding pharmacies for "the unlawful marketing and sales of non-FDA approved counterfeit and compounded semaglutide products claiming to contain semaglutide." The suit included allegations of false advertising, trademark infringement, and unlawful sales of non-FDA-approved compounded products
The FDA is currently evaluating whether GLP-1 medications may increase the risk of suicidal thoughts or actions
With Bioverse, starting your treatment is as simple as opening your package and following our easy-to-use instructions
Semaglutide is a GLP-1 analog peptide that is designed to influence your brain to regulate appetite and reduce food intake
Pricing is transparent before intake, cancellation is a nonissue because the service is not subscription based, no pressure tactics are deployed, and compounded medication limitations are clearly disclosed